Evaluation of artemisone combinations in Aotus monkeys infected with Plasmodium falciparum

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 8, 2009, Pages 3592-3594

  Obaldia III, Nicanor ^a   Kotecka, Barbara M ^b   Edstein, Michael D ^b   Haynes, Richard K ^c   Fugmann, Burkhard ^d   Kyle, Dennis E ^b   Rieckmann, Karl H ^b  

^a Malaria Drug and Vaccine Evaluation Center   (Panama)

^b AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^c HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^d Bayer Innovation   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMISONE; CLINDAMYCIN; MEFLOQUINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AOTUS; ARTICLE; CONTROLLED STUDY; MALARIA FALCIPARUM; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT RESPONSE;

AMODIAQUINE; ANIMALS; ANTIMALARIALS; AOTUS TRIVIRGATUS; ARTEMISININS; DRUG THERAPY, COMBINATION; MALARIA, FALCIPARUM; MEFLOQUINE; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME;

EID: 67749093299     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00471-09     Document Type: Article

References (25)

1. Adjuik, M., A. Babiker, P. Garner, P. Olliaro, W. Taylor, and N. White. 2004. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363:9-17.
2. Brewer, T. G., J. O. Peggins, S. J. Grate, J. M. Petras, B. S. Levine, P. J. Weina, J. Swearengen, M. H. Heiffer, and B. G. Schuster. 1994. Neurotoxicity in animals due to arteether and artemether. Trans. R. Soc. Trop. Med. Hyg. 88(Suppl. 1):S33-S36.
3. Brockman, A., R. N. Price, M. van Vugt, D. G. Heppner, D. Walsh, P. Sookto, T. Wimonwattrawatee, S. Looareesuwan, N. J. White, and F. Nosten. 2000. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Trans. R. Soc. Trop. Med. Hyg. 94:537-544.
4. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
5. Freireich, E. J., E. A. Gehan, D. P. Rall, L. H. Schmidt, and H. E. Skipper. 1966. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep. 50:219-244.
6. Haynes, R. K., B. Fugmann, J. Stetter, K. Rieckmann, H. D. Heilmann, H. W. Chan, M. K. Cheung, W. L. Lam, H. N. Wong, S. L. Croft, L. Vivas, L. Rattray, L. Stewart, W. Peters, B. L. Robinson, M. D. Edstein, B. Kotecka, D. E. Kyle, B. Beckermann, M. Gerisch, M. Radtke, G. Schmuck, W. Steinke, U. Wollborn, K. Schmeer, and A. Romer. 2006. Artemisone-a highly active antimalarial drug of the artemisinin class. Angew. Chem. Int. Ed. Engl. 45:2082-2088.
7. Karema, C., C. I. Fanello, C. van Overmeir, J. P. van Geertruyden, W. van Doren, D. Ngamije, and U. D'Alessandro. 2006. Safety and efficacy of dihydroartemisinin/ piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. Trans. R. Soc. Trop. Med. Hyg. 100:1105-1111.
8. Kotecka, B. M., and K. H. Rieckmann. 1995. In vivo-in vitro model to assess chloroquine activity in monkeys. Chemotherapy 41:134-140.
9. Kremsner, P. G., S. Winkler, C. Brandts, S. Neifer, U. Bienzle, and W. Graninger. 1994. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J. Infect. Dis. 169:467-470.
10. McGready, R., T. Cho, Samuel, L. Villegas, A. Brockman, M. van Vugt, S. Looareesuwan, N. J. White, and F. Nosten. 2001. Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. Trans. R. Soc. Trop. Med. Hyg. 95:651-656.
11. Mutabingwa, T. K., D. Anthony, A. Heller, R. Hallett, J. Ahmed, C. Drakeley, B. M. Greenwood, and C. J. Whitty. 2005. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet 365:1474- 1480.
12. Nagelschmitz, J., B. Voith, G. Wensing, A. Roemer, B. Fugmann, R. K. Haynes, B. M. Kotecka, K. H. Rieckmann, and M. D. Edstein. 2008. First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone. Antimicrob. Agents Chemother. 52:3085-3091.
13. Nosten, F., M. van Vugt, R. Price, C. Luxemburger, K. L. Thway, A. Brockman, R. McGready, F. ter Kuile, S. Looareesuwan, and N. J. White. 2000. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356:297-302.
14. Olliaro, P., C. Nevill, J. LeBras, P. Ringwald, P. Mussano, P. Garner, and P. Brasseur. 1996. Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 348:1196-1201.
15. Peters, W., and B. L. Robinson. 1999. Malaria, p. 757-773. In O. Zak and M. A. Sande (ed.), Handbook of animal models of infection. Experimental models in antimicrobial chemotherapy. Academic Press, New York, NY.
16. Ramharter, M., D. Burkhardt, J. Nemeth, A. A. Adegnika, and P. G. Kremsner. 2006. In vitro activity of artemisone compared with artesunate against Plasmodium falciparum. Am. J. Trop. Med. Hyg. 75:637-639.
17. Ramharter, M., S. Oyakhirome, P. Klein Klouwenberg, A. A. Adegnika, S. T. Agnandji, M. A. Missinou, P. B. Matsiegui, B. Mordmuller, S. Borrmann, J. F. Kun, B. Lell, S. Krishna, W. Graninger, S. Issifou, and P. G. Kremsner. 2005. Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. Clin. Infect. Dis. 40:1777-1784.
18. Rieckmann, K. H. 2006. The chequered history of malaria control: are new and better tools the ultimate answer? Ann. Trop. Med. Parasitol. 100:647-662.
19. Rieckmann, K. H. 1971. Determination of the drug sensitivity of Plasmodium falciparum. JAMA 217:573-578.
20. Rieckmann, K. H., G. M. Trenholme, R. L. Williams, P. E. Carson, H. Frischer, and R. E. Desjardins. 1974. Prophylactic activity of mefloquine hydrochloride (WR 142490) in drug-resistant malaria. Bull. W. H. O. 51:375-377.
21. Vivas, L., L. Rattray, L. B. Stewart, B. L. Robinson, B. Fugmann, R. K. Haynes, W. Peters, and S. L. Croft. 2007. Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo. J. Antimicrob. Chemother. 59:658-665.
22. Wesche, D. L., M. A. DeCoster, F. C. Tortella, and T. G. Brewer. 1994. Neurotoxicity of artemisinin analogs in vitro. Antimicrob. Agents Chemother. 38:1813-1819.
23. White, N. J. 2004. Antimalarial drug resistance. J. Clin. Investig. 113:1084-1092.
24. Zongo, I., G. Dorsey, N. Rouamba, C. Dokomajilar, M. Lankoande, J. B. Ouedraogo, and P. J. Rosenthal. 2005. Amodiaquine, sulfadoxine- pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. Am. J. Trop. Med. Hyg. 73:826-832.
25. Zongo, I., G. Dorsey, N. Rouamba, H. Tinto, C. Dokomajilar, R. T. Guiguemde, P. J. Rosenthal, and J. B. Ouedraogo. 2007. Artemether- lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. Lancet 369:491-498.